FdaApplication
NDA 022325
Identifiers
- fda_app_no: NDA022325
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2008-12-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXTERONE | AMIODARONE HYDROCHLORIDE | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| NEXTERONE | AMIODARONE HYDROCHLORIDE | 150MG/100ML (1.5MG/ML) | INJECTABLE;INJECTION |
| NEXTERONE | AMIODARONE HYDROCHLORIDE | 360MG/200ML (1.8MG/ML) | INJECTABLE;INJECTION |
3 products